Vaishali Pharma Limited (NSE:VAISHALI)

Market Cap	1.54B
Revenue (ttm)	990.26M
Net Income (ttm)	8.17M
Shares Out	120.94M
EPS (ttm)	0.60
PE Ratio	210.42
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,056,171
Average Volume	571,894
Open	12.26
Previous Close	12.34
Day's Range	12.24 - 13.10
52-Week Range	10.30 - 24.91
Beta	0.25
RSI	54.70
Earnings Date	Jul 29, 2025

About Vaishali Pharma

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 27
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VAISHALI

Financial Performance

In 2024, Vaishali Pharma's revenue was 990.26 million, an increase of 14.77% compared to the previous year's 862.80 million. Earnings were 8.17 million, an increase of 13.69%.